CGRP receptor antagonism and migraine therapy

Current Protein and Peptide Science

Volumn 14, Issue 5, 2013, Pages 386-392

  Edvinsson, Lars ^a,b   Warfvinge, Karin ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Glostrup Research Institute   (Denmark)

Author keywords

CGRP; CGRP receptor antagonists; Migraine; Telcagepant; Trigeminovascular reflex

Indexed keywords

ALD 403; AMG 334; BI 44370; BMS 927711; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN RECEPTOR LIKE RECEPTOR; ELETRIPTAN; ERGOT DERIVATIVE; LBR 101; LY 2951742; MESSENGER RNA; MK 3207; MONOCLONAL ANTIBODY; OLCEGEPANT; PLACEBO; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RIZATRIPTAN; SUMATRIPTAN; TELCAGEPANT; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GENE MUTATION; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOREACTIVITY; LIVER FUNCTION TEST; MEAN ARTERIAL PRESSURE; MIGRAINE; NAUSEA; NERVE FIBER C; NEUROGENIC INFLAMMATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHONOPHOBIA; PHOTOPHOBIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIDE EFFECT; SYNAPSE; THALAMUS; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

AZEPINES; CALCITONIN GENE-RELATED PEPTIDE; DIPEPTIDES; HUMANS; IMIDAZOLES; MIGRAINE DISORDERS; PEPTIDE FRAGMENTS; QUINAZOLINES; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 84882577435     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990055     Document Type: Article

References (40)

1. Ng-Mak, D. S.; Chen, Y. T.; Ho, T. W.; Stanford, B.; Roset, M. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases. Cephalalgia 2012, 32, 875-887.
2. Edvinsson, L.; Villalon, C. M. Maassenvandenbrink A, Basic mechanisms of migraine and its acute treatment. Pharmacol. Ther., 2012.
3. Ho, T. W.; Edvinsson, L.; Goadsby, P. J. CGRP and its receptors provide new insights into migraine pathophysiology. Nat. Rev. Neurol., 2010, 6, 573-582.
4. Akerman, S.; Holland, P. R.; Goadsby, P. J. Diencephalic and brainstem mechanisms in migraine. Nat. Rev. Neurosci., 2011, 12, 570-584.
5. Edvinsson, L.; Krause, D. N. Cerebral Blood Flow and Metabolism. Philadelphia, Lippincott Williams Wilkins; 2002.
6. Edvinsson L. Tracing neural connections to pain pathways with relevance to primary headaches. Cephalalgia, 2011, 31, 737-747.
7. McLatchie, L. M.; Fraser, N. J.; Main, M. J.; Wise, A.; Brown, J.; Thompson, N.; Solari, R.; Lee, M. G.; Foord, S. M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptorlike receptor. Nature, 1998, 393, 333-339.
8. Walker, C. S.; Conner, A. C.; Poyner, D. R.; Hay, D. L. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol. Sci., 2010, 31, 476-483.
9. Edvinsson, L.; Chan, K. Y.; Eftekhari, S.; Nilsson, E.; de Vries, R.; Saveland, H.; Dirven, C. M.; Danser, A. H.; MaassenVanDen-Brink, A. Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia, 2010, 30,1233-1240.
10. Eftekhari, S.; Salvatore, C. A.; Calamari, A.; Kane, S. A.; Tajti, J.; Edvinsson, L.; Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience, 2010, 169, 683-696.
11. Asghar, M. S.; Hansen, A. E.; Amin, F. M.; van der Geest, R. J.; Koning, P.; Larsson, H. B.; Olesen, J.; Ashina, M. Evidence for a vascular factor in migraine. Ann. Neurol., 2011, 69, 635-645.
12. Oliver, K. R.; Wainwright, A.; Edvinsson, L.; Pickard, J. D.; Hill, R. G. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J. Cereb. Blood Flow Metab., 2002, 22, 620-629.
13. Eftekhari, S.; Edvinsson, L. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci., 2011, 12, 112.
14. Liu, Y.; Broman, J.; Edvinsson, L. Central projections of the sensory innervation of the rat middle meningeal artery. Brain Res., 2008, 1208, 103-110.
15. Lennerz, J. K.; Ruhle, V.; Ceppa, E. P.; Neuhuber, W. L.; Bunnett, N. W.; Grady, E. F.; Messlinger, K. Calcitonin receptor-like receptor (CLR).; receptor activity-modifying protein 1 (RAMP1).; and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system, differences between peripheral and central CGRP receptor distribution. J. Comp. Neurol., 2008, 507,1277-1299.
16. Kawai, Y.; Takami, K.; Shiosaka, S.; Emson, P. C.; Hillyard, C. J.; Girgis, S.; MacIntyre, I.; Tohyama, M. Topographic localization of calcitonin gene-related peptide in the rat brain, an immunohistochemical analysis. Neuroscience, 1985, 15, 747-763.
17. Weiller, C.; May, A.; Limmroth, V.; Juptner, M.; Kaube, H.; Schayck, R. V.; Coenen, H. H.; Diener, H. C. Brain stem activation in spontaneous human migraine attacks. Nat. Med., 1995, 1, 658-660.
18. Goadsby, P. J.; Edvinsson, L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain, 1994, 117(Pt 3), 427-434.
19. Durham, P. L.; Russo, A. F. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J. Neurosci., 1999, 19, 3423-3429.
20. Csati, A.; Tajti, J.; Tuka, B.; Edvinsson, L.; Warfvinge, K. Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion --interaction with the sensory system. Brain Res., 2012, 1435, 29-39.
21. Eftekhari, S.; Warfvinge, K.; Blixt, F.; Edvinsson, L. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. In EHMTIC2012; London.; Edited by PJ Goadsby DV, The Migraine Trust, 2012.
22. Poyner, D. R.; Sexton, P. M.; Marshall, I.; Smith, D. M.; Quirion, R.; Born, W.; Muff, R.; Fischer, J. A.; Foord, S. M. International Union of Pharmacology. XXXII. The mammalian calcitonin generelated peptides.; adrenomedullin.; amylin.; and calcitonin receptors. Pharmacol. Rev., 2002, 54, 233-246.
23. Moore, E. L.; Salvatore, C. A. Targeting a family B GPCR/RAMP receptor complex, CGRP receptor antagonists and migraine. Brit. J. Pharmacol., 2012, 166, 66-78.
24. Mallee, J. J.; Salvatore, C. A.; LeBourdelles, B.; Oliver, K. R.; Longmore, J.; Koblan, K. S.; Kane, S. A. Receptor activitymodifying protein 1 determines the species selectivity of nonpeptide CGRP receptor antagonists. J. Biol. Chem., 2002, 277, 14294-14298.
25. ter Haar, E.; Koth, C. M.; Abdul-Manan, N.; Swenson, L.; Coll, J. T.; Lippke, J. A.; Lepre, C. A.; Garcia-Guzman, M.; Moore, J. M. Crystal structure of the ectodomain complex of the CGRP receptor.; a class-B GPCR.; reveals the site of drug antagonism. Structure, 2010, 18, 1083-1093.
26. Petersen, K. A.; Lassen, L. H.; Birk, S.; Lesko, L.; Olesen, J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin. Pharmacol. Ther., 2005, 77, 202-213.
27. Petersen, K. A.; Birk, S.; Lassen, L. H.; Kruuse, C.; Jonassen, O.; Lesko, L.; Olesen, J. The CGRP-antagonist.; BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia, 2005, 25, 139-147.
28. Petersen, K. A.; Nilsson, E.; Olesen, J.; Edvinsson, L. Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia, 2005, 25, 424-432.
29. Edvinsson, L.; Nilsson, E.; Jansen-Olesen, I. Inhibitory effect of BIBN4096BS.; CGRP(8-37).; a CGRP antibody and an RNASpiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br. J. Pharmacol., 2007, 150, 633-640.
30. Zartman, C. B.; Bell, I. M.; Gallicchio, S. N.; Graham, S. L.; Kane, S. A.; Mallee, J. J.; Rutledge, R. Z.; Salvatore, C. A.; Vacca, J. P.; Williams, T. M. Identification of a novel RAMP-independent CGRP receptor antagonist. Bioorg. Med. Chem. Lett., 2011, 21, 6705-6708.
31. Salvatore, C. A.; Kane, S. A. CGRP receptor antagonists, toward a novel migraine therapy. Curr. Pharm. Biotechnol., 2011, 12, 1671-1680.
32. Olesen, J.; Diener, H. C.; Husstedt, I. W.; Goadsby, P. J.; Hall, D.; Meier, U.; Pollentier, S.; Lesko, L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med., 2004, 350,1104-1110.
33. Edvinsson, L.; Linde, M. New drugs in migraine treatment and prophylaxis, telcagepant and topiramate. Lancet, 2010, 376, 645-655.
34. Connor, K. M.; Shapiro, R. E.; Diener, H. C.; Lucas, S.; Kost, J.; Fan, X.; Fei, K.; Assaid, C.; Lines, C.; Ho, T.W. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology, 2009, 73, 970-977.
35. Ho, A. P.; Dahlof, C. G.; Silberstein, S. D.; Saper, J. R.; Ashina, M.; Kost, J. T.; Froman, S.; Leibensperger, H.; Lines, C. R.; Ho, T. W. Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia, 2010, 30, 1443-1457.
36. Ho, T. W.; Ferrari, M. D.; Dodick, D. W.; Galet, V.; Kost, J.; Fan, X.; Leibensperger, H.; Froman, S.; Assaid, C.; Lines, C.; Koppen, H.; Winner, P. K. Efficacy and tolerability of MK-0974 (telcagepant).; a new oral antagonist of calcitonin gene-related peptide receptor.; compared with zolmitriptan for acute migraine, a randomised.; placebo-controlled.; parallel-treatment trial. Lancet, 2008, 372, 2115-2123.
37. Diener, H. C.; Barbanti, P.; Dahlof, C.; Reuter, U.; Habeck, J.; Podhorna, J. BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks, results from a phase II study. Cephalalgia, 2011, 31, 573-584.
38. Tong, G.; Savant, I.; Jariwala, N.; Burt, D.; Zheng, N.; Buzescu, A.; Bertz, R.; Keswani, S.; Marcus, R. Phase I single and multiple dose study to evaluate the safety.; tolerability.; and pharmacokinetics of BMS-927711 in healthy subjects. In EHMTIC2012; London.; Edited by PJ Goadsby DV, The Migraine Trust, 2012.
39. Ho, T. W.; Mannix, L. K.; Fan, X.; Assaid, C.; Furtek, C.; Jones, C. J.; Lines, C. R.; Rapoport, A. M. group MKPs, Randomized controlled trial of an oral CGRP receptor antagonist.; MK-0974.; in acute treatment of migraine. Neurology, 2008, 70, 1304-1312.
40. Connor, K. M.; Aurora, S. K.; Loeys, T.; Ashina, M.; Jones, C.; Giezek, H.; Massaad, R.; Williams-Diaz, A.; Lines, C.; Ho, T. W. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. Headache, 2011, 51, 73-84.